Your browser doesn't support javascript.
loading
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world.
Pérez, Ana Belén; Chueca, Natalia; García-Deltoro, Miguel; Martínez-Sapiña, Ana María; Lara-Pérez, María Magdalena; García-Bujalance, Silvia; Aldámiz-Echevarría, Teresa; Vera-Méndez, Francisco Jesús; Pineda, Juan Antonio; Casado, Marta; Pascasio, Juan Manuel; Salmerón, Javier; Alados-Arboledas, Juan Carlos; Poyato, Antonio; Téllez, Francisco; Rivero-Juárez, Antonio; Merino, Dolores; Vivancos-Gallego, María Jesús; Rosales-Zábal, José Miguel; García, Federico.
Afiliação
  • Pérez AB; Clinical Microbiology Unit, University Hospital Reina Sofía. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
  • Chueca N; Clinical Microbiology Unit, University Hospital San Cecilio, Instituto de Investigacion Biosanitaria Ibs.Granada, Granada, Spain.
  • García-Deltoro M; Infectious Diseases Service, Hospital General de Valencia, Valencia, Spain.
  • Martínez-Sapiña AM; Clinical Microbiology Unit, Hospital Miguel Servet, Zaragoza, Spain.
  • Lara-Pérez MM; Clinical Microbiology Unit, Hospital Nuestra Señora de la Candelaria, Tenerife, Spain.
  • García-Bujalance S; Clinical Microbiology Unit, University Hospital La Paz, Madrid, Spain.
  • Aldámiz-Echevarría T; Infectious Diseases Unit, Hospital Gregorio Marañón, Madrid, Spain.
  • Vera-Méndez FJ; Infectious Diseases Unit, University Hospital Santa Lucía, Cartagena, Spain.
  • Pineda JA; Infectious Diseases Unit, University Hospital Nuestra Señora de Valme, Sevilla, Spain.
  • Casado M; Hepatology Unit, Complejo Hospitalario Torrecárdenas, Almería, Spain.
  • Pascasio JM; Hepatology Unit, University Hospital Virgen del Rocío, IBIS Instituto de Biomedicina de Sevilla, CIBERehd, Seville, Spain.
  • Salmerón J; Hepatology Unit, University Hospital San Cecilio Granada, Instituto de Investigación Biosanitaria Ibs.Granada, CIBERehd, Granada, Spain.
  • Alados-Arboledas JC; Clinical Microbiology Unit, University Hospital Jerez, Cádiz, Spain.
  • Poyato A; Hepatology Unit, University Hospital Reina Sofía, Córdoba, Spain.
  • Téllez F; Infectious Diseases Unit, Hospital Puerto Real, Puerto Real, Cádiz, Spain.
  • Rivero-Juárez A; Infectious Diseases Unit, University Hospital Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain.
  • Merino D; Infectious Diseases Unit, University Hospital Juan Ramón Jiménez, Huelva, Spain.
  • Vivancos-Gallego MJ; Infectious Diseases Unit, University Hospital Ramón y Cajal, Madrid, Spain.
  • Rosales-Zábal JM; Hepatology Unit, Hospital Costa del Sol, Marbella, Málaga, Spain.
  • García F; Clinical Microbiology Unit, University Hospital San Cecilio, Instituto de Investigacion Biosanitaria Ibs.Granada, Granada, Spain. Electronic address: fegarcia@ugr.es.
J Hepatol ; 71(5): 876-888, 2019 11.
Article em En | MEDLINE | ID: mdl-31279901

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Sulfonamidas / Benzimidazóis / Carbamatos / Prolina / Hepatite C / Proteínas não Estruturais Virais / Hepacivirus / Ritonavir Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Sulfonamidas / Benzimidazóis / Carbamatos / Prolina / Hepatite C / Proteínas não Estruturais Virais / Hepacivirus / Ritonavir Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article